YFY Biotech Management Company
About Us
Company Profile
Management Team
Capital Funds
Portfolio
News
Contact Us
繁體
English
News
SEARCH
Year
2024
2023
2022
2021
2020
2019
2018
2017
Aug 26, 2020
中裕(4147)獲新冠病毒單株抗體全球獨家授權 明年啟動人體臨床
READ MORE
Aug 26, 2020
中裕(4147)：取得新冠肺炎病毒單株抗體授權
READ MORE
Aug 14, 2020
轉型奏效！永昕(4726)Q2每股純益0.62元 創十年新高
READ MORE
Aug 14, 2020
台微體(4152)新冠肺炎治療新方案TLC19 申請臨床試驗
READ MORE
Aug 8, 2020
永昕(4726)新廠拚後年投產
READ MORE
Aug 3, 2020
台微體(4152)HCQ藥 將臨床試驗
READ MORE
Jul 31, 2020
負壓治療技術 睡眠呼吸中止症的防疫新選擇
READ MORE
Jul 17, 2020
中裕(4147)愛滋藥 本季在歐上市
READ MORE
prev
4
5
6
7
8
9
10
next
YFY Biotech Management Company